Baillie Gifford & Co’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,406
Closed -$14.9K 302
2023
Q2
$14.9K Hold
12,406
﹤0.01% 292
2023
Q1
$18.9K Hold
12,406
﹤0.01% 346
2022
Q4
$46.8K Buy
12,406
+305
+3% +$1.61K ﹤0.01% 298
2022
Q3
$60K Buy
12,101
+535
+5% +$3K ﹤0.01% 297
2022
Q2
$54K Buy
11,566
+668
+6% +$4.08K ﹤0.01% 299
2022
Q1
$82K Buy
10,898
+298
+3% +$2.41K ﹤0.01% 298
2021
Q4
$94K Hold
10,600
﹤0.01% 298
2021
Q3
$107K Buy
+10,600
New +$120K ﹤0.01% 282

Other funds holding PTRA

Baillie Gifford & Co's PTRA Position: Q3 2023 in Review

Baillie Gifford & Co sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 12,406 shares — an estimated $14.9K sold.

Baillie Gifford & Co first reported a position in PTRA in Q3 2021 and held it in 8 quarters. The position peaked at $107K in Q3 2021. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Baillie Gifford & Co reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 12,406 Proterra Inc. Common Stock shares in Q3 2023, an estimated $14.9K.
  • Baillie Gifford & Co first reported a position in Proterra Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Baillie Gifford & Co's Proterra Inc. Common Stock position peaked at $107K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Baillie Gifford & Co's 13F filing for Q3 2023, filed 13 Nov 2023.